中 | EN

About Us

Committed to providing customers with independently
developed advanced proton therapy systems

About Us

Shanghai APACTRON Particle Equipment Co., Ltd. is an industrialized company controlled by Shanghai Lianhe Investment Co., Ltd., a subsidiary of the Shanghai State owned Assets Supervision and Administration Commission, specializing in particle therapy equipment. It is committed to providing customers with independently developed advanced proton therapy systems and collaborative innovative solutions covering "center construction proton therapy clinical research research research research research research research research transformation".

In June 2023, Lianying invested in Aipuqiang, forming a complementary alliance that will help break the technological monopoly and accelerate the promotion of proton therapy in China.

Collaboration between industry, academia, research and medical institutions

Through in-depth cooperation with the Chinese Academy of Sciences, Shanghai Light Source, Shanghai Institute of Advanced Research, Ruijin Hospital affiliated to Shanghai Jiaotong University School of Medicine, and industrial partners, Eptrong has accelerated the promotion of proton therapy and prospective scientific research, and popularized proton therapy technology and service accessibility in China.
  • 42term
    Exclusive core patent
  • 10RMB100mn
    Accumulated R&D investment
  • 360°
    Compact rotating frame treatment angle

History

  • 2012
    2012.02
    Project initiation
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2014
    2014.12
    Proton center starts construction
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2016
    2016.11
    Accelerator system installation
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2017
    2017.11
    Rotating rack installation
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2018
    2018.08
    Academician and expert review
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2018
    2018.09
    Registration testing
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2021
    2021.01
    Complete innovation application
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2021
    2021.06
    Complete registration testing
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2021
    2021.11
    First clinical trial inclusion
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2022
    2022.06
    Complete clinical trials
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • 2022
    2022.09
    Approved for listing
    After ten years of sharpening the sword, we have successfully developed the first domestically produced proton therapy demonstration device, breaking the foreign monopoly and solving the bottleneck problem. We have achieved independent and controllable non-invasive treatment of high-end proton therapy devices, benefiting domestic cancer patients
  • Project initiation
    2012
  • Proton center starts construction
    2014
  • Accelerator system installation
    2016
  • Rotating rack installation
    2017
  • Academician and expert review
    2018
  • Registration testing
    2018
  • Complete innovation application
    2021
  • Complete registration testing
    2021
  • First clinical trial inclusion
    2021
  • Complete clinical trials
    2022
  • Approved for listing
    2022

Honor

  • Aipuqiang led the project application and won the special prize of the 2024 Shanghai Industry University Research Award
  • Won the first prize in the enterprise group of the Shanghai Small and Medium sized Enterprise "Double Creation" Competition
  • Top 50 Innovative Development Companies in 2021
  • Top 10 Independent Innovative Medical Device Products of 2023
  • Third Prize in the 2024 Shanghai SME Innovation and Entrepreneurship Competition
  • First Prize in the 2024 Shanghai Small and Medium sized Enterprise Innovation and Entrepreneurship Competition (Enterprise Group)
  • Best Team of the First "Proton Cup" Fun Sports Games in 2024
  • Top 50 Innovative Development Companies
  • Innovative Cases of Party Building Work
  • certificate of honor
  • Shanghai High tech Achievement Transformation Project
  • Shanghai May Day Labor Award
  • Top Ten Project Awards
  • Outstanding Contribution Award
  • Advanced grassroots party organizations

Contact Us

Proton radiotherapy is the development trend of precision cancer treatment in the future
According to the construction requirements of the hospital proton center, please contact us to tailor a one-stop proton therapy system solution for you

Contact Us Join Us
Building domestic high-end particle therapy technology, benefiting cancer patients, and supporting the Healthy China strategy
  • Email

    marketing@aptr.com.cn

  • Address

    605 Xingwen Road, Jiading District, Shanghai

  • Tel/Fax

    +86-21-59559737/+86-21-69152669

Copyright © 2025 Shanghai APACTRON Particle Equipment Co., Ltd.